DOD
Search
Discussions
Biomedical Jobmarket
News
DOD Alert
Edit DOD
 
ACCOUNT
Login
Register
Forgotten Password?
 
 
Neuroendocrine immuno-ontogeny of the pathogenesis of autoimmune disease in the nonobese diabetic (NOD) mouse.
 
Diabetes OD > Diabetes Pathogenesis > T1DM > Autoimmunity > NOD mouse > Postnatal Pancreatic Development > Macrophage Infiltration > Journal Article

(Journal Article): Neuroendocrine immuno-ontogeny of the pathogenesis of autoimmune disease in the nonobese diabetic (NOD) mouse.
 
Homo-Delarche F (Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universite Paris 7/D.Diderot, Paris, France.)
 
IN: Ilar J 2004; 45(3):237-258

Fulltext:    HTML  PDF

ABSTRACT: Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease in which insulin-producing beta cells of the pancreatic islets of Langerhans are destroyed. The nonobese diabetic (NOD) mouse is one of the rare spontaneous models that enable the study of prediabetic pancreatic events. The etiology of the autoimmune attack in human and animal T1D is still unknown, but genetic and environmental factors are involved in both cases. Although several autoantigens have been identified and defective immune-system regulation is implicated, this information does not satisfactorily explain the generally accepted beta-cell specificity of the disease or how so many and diverse environmental factors intervene in its pathogenesis. Based on data obtained from evaluating glucose homeostasis in a variety of situations, particularly stress and cytokine administration, in young prediabetic NOD mice, the author hypothesizes that the islet of Langerhans is a major actor, and its altered regulation through environmentally induced insulin resistance might reveal latent T1D. It is also postulated that T1D pathogenesis might be linked to abnormal pancreas development, probably due to disturbances of glutamic acid decarboxylase (GAD)+ innervation phagocytosis by defective macrophages during the early postnatal period. Also discussed is the role of defective presentation of pancreatic hormones and GAD in the thymus, and its potential repercussion on T-cell tolerance. Observations have demonstrated that the diabetogenic process in the NOD mouse is extremely complex, involving neuroendocrine immune interaction from fetal life onward.

TYPE OF PUBLICATION: Review

REFERENCES:

  1. Abiru N, Yu L, Miao D, Maniatis AK, Liu E, Moriyama H, Eisenbarth GS. Transient insulin autoantibody expression independent of development of diabetes: Comparison of NOD and NOR strains. J Autoimmun 2001. 17:1-6.
  2. Adams TE, Alpert S, Hanahan D. Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic beta cells. Nature 1987. 325:223-228.
  3. Ader DN, Johnson SB, Huang SW, Riley WJ. Group size, cage shelf level, and emotionality in non-obese diabetic mice: Impact on onset and incidence of IDDM. Psychosom Med 1991. 53:313-321.
  4. Aerts L, Assche FA. Ultrastructural changes of the endocrine pancreas in pregnant rats. Diabetologia 1975. 11:285-289.
  5. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV. Insulin resistance of puberty: A defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991. 72:277-282.
  6. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty: A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986. 315:215-219.
  7. Amrani A, Chaouloff F, Mormede P, Dardenne M, Homo-Delarche F. Glucose, insulin, and open field responses to immobilization in nonobese diabetic (NOD) mice. Physiol Behav 1994. 56:241-246.
  8. Amrani A, Durant S, Throsby M, Coulaud J, Dardenne M, Homo-Delarche F. Glucose homeostasis in the nonobese diabetic mouse at the prediabetic stage. Endocrinology 1998. 139:1115-1124.
  9. Amrani A, Jafarian-Tehrani M, Mormede P, Durant S, Pleau JM, Haour F, Dardenne M, Homo-Delarche F. Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage. J Endocrinol 1996. 148:139-148.
  10. Andre I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D. Checkpoints in the progression of autoimmune disease: Lessons from diabetes models. Proc Natl Acad Sci U S A 1996. 93:2260-2263.
  11. Ansar Ahmed S, Penhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases: Mechanisms of sex hormone action. Am J Pathol 1985. 121:531-551.
  12. Asplund K. Effects of glucose on insulin biosynthesis in foetal and newborn rats. Horm Metab Res 1973. 5:410-415.
  13. Atkinson MA, Eisenbarth GS. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001. 358:221-229.
  14. Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: As good as it gets? Nat Med 1999. 5:601-604.
  15. Atwater I, Gondos B, DiBartolomeo R, Bazaes R, Jovanovic L. Pregnancy hormones prevent diabetes and reduce lymphocytic infiltration of islets in the NOD mouse. Ann Clin Lab Sci 2002. 32:87-92.
  16. Augstein P, Dunger A, Heinke P, Wachlin G, Berg S, Hehmke B, Salzsieder E. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells. Biochem Biophys Res Commun 2003. 304:378-384.
  17. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994. 15:516-542.
  18. Bach JF. Immunotherapy of type 1 diabetes: Lessons for other autoimmune diseases. Arthritis Res 2002. 4(Suppl 3):S3-S15.
  19. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002. 347:911-920.
  20. Bao M, Yang Y, Jun HS, Yoon JW. Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 2002. 168:5369-5375.
  21. Barker DJ. In utero programming of chronic disease. Clin Sci (Lond) 1998. 95:115-128.
  22. Bateman A, Singh A, Kral T, Solomon S. The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 1989. 10:92-112.
  23. Beales PE, Castri F, Valiant A, Rosignoli G, Buckley L, Pozzilli P. Adrenalitis in the non-obese diabetic mouse. Autoimmunity 2002. 35:329-333.
  24. Beales PE, Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: Implications for human type 1 diabetes. Diabetes Metab Res Rev 2002. 18:114-117.
  25. Benhamou PY, Mullen Y, Clare-Salzler M, Sangkharat A, Benhamou C, Shevlin L, Go VL. Essential fatty acid deficiency prevents autoimmune diabetes in nonobese diabetic mice through a positive impact on antigen-presenting cells and Th2 lymphocytes. Pancreas 1995. 11:26-37.
  26. Bennett ST, Lucassen AM, Gough SC, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, Nerup J, Bouzekri N, Cambon-Thomsen A, Rønningen KS, Barnett AH, Bain SC, Todd JA. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995. 9:284-292.
  27. Bergerot I, Fabien N, Maguer V, Thivolet C. Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes. Clin Exp Immunol 1995. 102:335-340.
  28. Bergstrom E, Hernell O, Persson LA, Vessby B. Insulin resistance syndrome in adolescents. Metabolism 1996. 45:908-914.
  29. Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr Rev 1996. 17:64-102.
  30. Beyan H, Buckley LR, Yousaf N, Londei M, Leslie RD. A role for innate immunity in type 1 diabetes? Diabetes Metab Res Rev 2003. 19:89-100.
  31. Bluthe RM, Jafarian-Tehrani M, Michaud B, Haour F, Dantzer R, Homo-Delarche F. Increased sensitivity of prediabetic nonobese diabetic mouse to the behavioral effects of IL-1. Brain Behav Immun 1999. 13:303-314.
  32. Bock T, Kjaer TW, Jorgensen M, Josefsen K, Rygaard J, Buschard K. Reduction of diabetes incidence in NOD mice by neonatal glucose treatment. Apmis 1991. 99:989-992.
  33. Boitard C, Villa MC, Becourt C, Gia HP, Huc C, Sempe P, Portier MM, Bach JF. Peripherin: An islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products. Proc Natl Acad Sci U S A 1992. 89:172-176.
  34. Bruining GJ, Batstra MR. Recent advances in immunology of type 1 diabetes mellitus: A congenital disorder? Diabetes Nutr Metab 1999. 12:68-74.
  35. Buschard K. The functional state of the beta cells in the pathogenesis of insulin-dependent diabetes mellitis. Autoimmunity 1991. 10:65-69.
  36. Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS, Tamborlane WV. Increased insulin secretion in puberty: A compensatory response to reductions in insulin sensitivity. J Pediatr 1989. 114:963-967.
  37. Casteels KM, Gysemans CA, Waer M, Bouillon R, Laureys JM, Depovere J, Mathieu C. Sex difference in resistance to dexamethasone-induced apoptosis in NOD mice: Treatment with 1,25(OH)2D3 restores defect. Diabetes 1998. 47:1033-1037.
  38. Chentoufi AA, Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: The mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 2002. 51:1383-1390.
  39. Christofori G, Naik P, Hanahan D. Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during beta-cell tumorigenesis. Nat Genet 1995. 10:196-201.
  40. Clark PM. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis. Eur J Pediatr 1998. 157(Suppl 1):S7-S10.
  41. Conti A, Maestroni GJ. Role of the pineal gland and melatonin in the development of autoimmune diabetes in non-obese diabetic mice. J Pineal Res 1996. 20:164-172.
  42. Dahlquist GG, Boman JE, Juto P. Enteroviral RNA and IgM antibodies in early pregnancy and risk for childhood-onset IDDM in offspring. Diabetes Care 1999. 22:364-365.
  43. Dahlquist G, Kallen B. Early neonatal events and the disease incidence in nonobese diabetic mice. Pediatr Res 1997. 42:489-491.
  44. Dahlquist GG, Patterson C, Soltesz G. Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 1999. 22:1698-1702.
  45. Dandona P, Aljada A, Chaudhuri A, Bandyopadhyay A. The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab 2003. 88:2422-2429.
  46. DeFronzo RA. Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 1997. 5:177-269.
  47. Delovitch TL, Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD. Immunity 1997. 7:727-738.
  48. Deltour L, Leduque P, Blume N, Madsen O, Dubois P, Jami J, Bucchini D. Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. Proc Natl Acad Sci U S A 1993. 90:527-531.
  49. Dubois-Lafforgue D, Mogenet L, Thebault K, Jami J, Krief P, Boitard C. Proinsulin 2 knockout NOD mice: A model for genetic variation of insulin gene expression in type 1 diabetes. Diabetes 2002. 51(Suppl 3):S489-S493.
  50. Durant S, Alves V, Coulaud J, El Hasnaoui A, Dardenne M, Homo-Delarche F. Attempts to pharmacologically modulate prolactin levels and type 1 autoimmune diabetes in the non-obese diabetic (NOD) mouse. J Autoimmun 1995. 8:875-885.
  51. Durant S, Alves V, Coulaud J, Homo-Delarche F. Nonobese diabetic (NOD) mouse dendritic cells stimulate insulin secretion by prediabetic islets. Autoimmunity 2002. 35:449-455.
  52. Durant S, Christeff N, Coulaud J, Nunez EA, Dardenne M, Homo-Delarche F. Basal concentrations of various steroids in the nonobese diabetic (NOD) mouse and effect of immobilization stress. Autoimmunity 1998. 28:249-258.
  53. Durant S, Coulaud J, Amrani A, el Hasnaoui A, Dardenne M, Homo-Delarche F. Effects of various environmental stress paradigms and adrenalectomy on the expression of autoimmune type 1 diabetes in the non-obese diabetic (NOD) mouse. J Autoimmun 1993. 6:735-751.
  54. Durant S, Geutskens S, Van Blokland SC, Coulaud J, Alves V, Pleau JM, Versnel M, Drexhage HA, Homo-Delarche F. Proapoptosis and antiapoptosis-related molecules during postnatal pancreas development in control and nonobese diabetic mice: Relationship with innervation. Lab Invest 2003. 83:227-239.
  55. Fadok VA, Bratton DL, Henson PM. Phagocyte receptors for apoptotic cells: Recognition, uptake, and consequences. J Clin Invest 2001. 108:957-962.
  56. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000. 68:437-446.
  57. Fernandes A, King LC, Guz Y, Stein R, Wright CV, Teitelman G. Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology 1997. 138:1750-1762.
  58. Fernandez-Real JM, Ricart W. Insulin resistance and inflammation in an evolutionary perspective: The contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 1999. 42:1367-1374.
  59. Finegood DT, Scaglia L, Bonner-Weir S. Dynamics of beta-cell mass in the growing rat pancreas: Estimation with a simple mathematical model. Diabetes 1995. 44:249-256.
  60. Fitzpatrick F, Christeff N, Durant S, Dardenne M, Nunez EA, Homo-Delarche F. Glucocorticoids in the nonobese diabetic (NOD) mouse: Basal serum levels, effect of endocrine manipulation and immobilization stress. Life Sci 1992. 50:1063-1069.
  61. Fitzpatrick F, Lepault F, Homo-Delarche F, Bach JF, Dardenne M. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology 1991. 129:1382-1390.
  62. Formby B, Schmid-Formby F, Jovanovic L, Peterson CM. The offspring of the female diabetic "nonobese diabetic" (NOD) mouse are large for gestational age and have elevated pancreatic insulin content: A new animal model of human diabetic pregnancy. Proc Soc Exp Biol Med 1987. 184:291-294.
  63. Fourlanos S, Narendran P, Colman P, Harrisson L. Fasting insulin, fasting glucose and insulin resistance is increased in pre-clinical type 1 diabetes. Diabetologia 2003. 46(Suppl 2):A14.
  64. Fox HS. Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med 1992. 175:1409-1412.
  65. French MB, Allison J, Cram DS, Thomas HE, Dempsey-Collier M, Silva A, Georgiou HM, Kay TW, Harrison LC, Lew AM. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 1997. 46:34-39.
  66. Fujimoto S, Tsuura Y, Ishida H, Tsuji K, Mukai E, Kajikawa M, Hamamoto Y, Takeda T, Yamada Y, Seino Y. Augmentation of basal insulin release from rat islets by preexposure to a high concentration of glucose. Am J Physiol Endocrinol Metab 2000. 279:E927-940.
  67. Fukata J, Imura H, Nakao K. Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function. J Endocrinol Invest 1994. 17:141-155.
  68. Funda DP, Kaas A, Bock T, Tlaskalova-Hogenova H, Buschard K. Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev 1999. 15:323-327.
  69. Garchon HJ, Luan JJ, Eloy L, Bedossa P, Bach JF. Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: Mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction. Eur J Immunol 1994. 24:380-384.
  70. Geenen V, Brilot F. Role of the thymus in the development of tolerance and autoimmunity towards the neuroendocrine system. Ann N Y Acad Sci 2003. 992:186-195.
  71. Geenen V, Lefebvre PJ. The intrathymic expression of insulin-related genes: Implications for pathophysiology and prevention of type 1 diabetes. Diabetes Metab Rev 1998. 14:95-103.
  72. Girard J, Ferre P, Pegorier JP, Duee PH. Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiol Rev 1992. 72:507-562.
  73. Granot M, Perlman R, Sprecher E, Tenenbaum G, Barzilai D, Vardi P. The role of beta cell maturity in the development of type I diabetes mellitus. Isr J Med Sci 1994. 30:22-25.
  74. Graves PM, Norris JM, Pallansch MA, Gerling IC, Rewers M. The role of enteroviral infections in the development of IDDM: Limitations of current approaches. Diabetes 1997. 46:161-168.
  75. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1-alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002. 51:1367-1374.
  76. Halbout P, Briand JP, Becourt C, Muller S, Boitard C. T cell response to preproinsulin I and II in the nonobese diabetic mouse. J Immunol 2002. 169:2436-2443.
  77. Halminen M, Veijola R, Reijonen H, Ilonen J, Akerblom HK, Knip M. Effect of polymorphism in the insulin gene region on IDDM susceptibility and insulin secretion: The Childhood Diabetes in Finland (DiMe) Study Group. Eur J Clin Invest 1996. 26:847-852.
  78. Hansen L, Jensen JN, Urioste S, Petersen HV, Pociot F, Eiberg H, Kristiansen OP, Hansen T, Serup P, Nerup J, Pedersen O. NeuroD/BETA2 gene variability and diabetes: No associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes 2000. 49:876-878.
  79. Hartling SG, Lindgren F, Dahlqvist G, Persson B, Binder C. Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity. Diabetes 1989. 38:1271-1274.
  80. Hattersley AT, Tooke JE. The fetal insulin hypothesis: An alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 1999. 353:1789-1792.
  81. Hawkins T, Gala RR, Dunbar JC. The effect of neonatal sex hormone manipulation on the incidence of diabetes in nonobese diabetic mice. Proc Soc Exp Biol Med 1993. 202:201-205.
  82. Hawkins TA, Gala RR, Dunbar JC. Prolactin modulates the incidence of diabetes in male and female NOD mice. Autoimmunity 1994. 18:155-162.
  83. Hawkins TA, Gala RR, Dunbar JC. The lymphocyte and macrophage profile in the pancreas and spleen of NOD mice: Percentage of interleukin-2 and prolactin receptors on immunocompetent cell subsets. J Reprod Immunol 1996. 32:55-71.
  84. Heath VL, Moore NC, Parnell SM, Mason DW. Intrathymic expression of genes involved in organ specific autoimmune disease. J Autoimmun 1998. 11:309-318.
  85. Heaton DA, Millward BA, Gray P, Tun Y, Hales CN, Pyke DA, Leslie RD. Evidence of beta cell dysfunction which does not lead on to diabetes: A study of identical twins of insulin dependent diabetics. Br Med J (Clin Res Ed) 1987. 294:145-146.
  86. Heaton DA, Millward BA, Gray IP, Tun Y, Hales CN, Pyke DA, Leslie RD. Increased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients. Diabetologia 1988. 31:182-184.
  87. Hill DJ, Hogg J. Growth factor control of pancreatic B cell hyperplasia. Baillieres Clin Endocrinol Metab 1991. 5:689-698.
  88. Hill DJ, Petrik J, Arany E, McDonald TJ, Delovitch TL. Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from pre-diabetic non-obese diabetic mice. J Endocrinol 1999. 161:153-165.
  89. Hollander PH, Asplin CM, Kniaz D, Hansen JA, Palmer JP. Beta-cell dysfunction in nondiabetic HLA identical siblings of insulin-dependent diabetics. Diabetes 1982. 31:149-153.
  90. Homo-Delarche F. Beta-cell behaviour during the prediabetic stage. Part II. Non-insulin-dependent and insulin-dependent diabetes mellitus. Diabetes Metab 1997. 23:473-505.
  91. Homo-Delarche F. Is pancreas development abnormal in the non-obese diabetic mouse, a spontaneous model of type I diabetes? Braz J Med Biol Res 2001. 34:437-447.
  92. Homo-Delarche F, Boitard C. Autoimmune diabetes: The role of the islets of Langerhans. Immunol Today 1996. 17:456-460.
  93. Homo-Delarche F, Dardenne M. The neuroendocrine-immune axis. Springer Semin Immunopathol 1993. 14:221-238.
  94. Homo-Delarche F, Durant S. Hormones, neurotransmitters and neuropeptides as modulators of lymphocyte functions. In: Rola-Pleszczynski M, ed. Hormones and Ageing. London: Academic Press 1994. p 383-409.
  95. Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez EA, Bach JF, Dardenne M. Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol 1991. 40:619-637.
  96. Homo-Delarche F, Throsby M, Rosmalen JG, Pleau J, Pelegri C, Coulaud J, Esling A, Durant S, Drexhage HA. Neonatal beta-cell hyperactivity in nonobese diabetic (NOD) and lymphocyte-deprived NODscid mice. Diabetologia 2003. 46(Suppl 2):A168.
  97. Honjin H. The innervation of the pancreas of the mouse, with special reference to the structure of the peripheral extension of the vegetative nervous system. J Comp Neurol 1956. 104:331-371.
  98. Hoorens A, Van de Casteele M, Kloppel G, Pipeleers D. Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 1996. 98:1568-1574.
  99. Hoorfar J, Buschard K, Dagnaes-Hansen F. Prophylactic nutritional modification of the incidence of diabetes in autoimmune non-obese diabetic (NOD) mice. Br J Nutr 1993. 69:597-607.
  100. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter MA, Lechler RI, Bloom SR. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 1999. 104:1051-1059.
  101. Hugl SR, White MF, Rhodes CJ. Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J Biol Chem 1998. 273:17771-17779.
  102. Huxtable SJ, Saker PJ, Haddad L, Walker M, Frayling TM, Levy JC, Hitman GA, O'Rahilly S, Hattersley AT, McCarthy MI. Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles. Diabetes 2000. 49:126-130.
  103. Hyoty H, Taylor KW. The role of viruses in human diabetes. Diabetologia 2002. 45:1353-1361.
  104. Iwata I, Nagafuchi S, Nakashima H, Kondo S, Koga T, Yokogawa Y, Akashi T, Shibuya T, Umeno Y, Okeda T, Shibata S, Kono S, Yasunami M, Ohkubo H, Niho Y. Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese. Diabetes 1999. 48:416-419.
  105. Jafarian-Tehrani M, Amrani A, Homo-Delarche F, Marquette C, Dardenne M, Haour F. Localization and characterization of interleukin-1 receptors in the islets of Langerhans from control and nonobese diabetic mice. Endocrinology 1995. 136:609-613.
  106. Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 1994. 43:667-675.
  107. Jansen A, Rosmalen JG, Homo-Delarche F, Dardenne M, Drexhage HA. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest? J Autoimmun 1996. 9:341-348.
  108. Jolicoeur C, Hanahan D, Smith KM. T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc Natl Acad Sci U S A 1994. 91:6707-6711.
  109. Jun HS, Yoon JW. A new look at viruses in type I diabetes. Diabetes Metab Res Rev 2003. 19:8-31.
  110. Juneja R, Hirsch IB, Naik RG, Brooks-Worrell BM, Greenbaum CJ, Palmer JP. Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism 2001. 50:1008-1013.
  111. Kaino Y, Hirai H, Ito T, Kida K. Insulin-like growth factor I (IGF-I) delays the onset of diabetes in non-obese diabetic (NOD) mice. Diabetes Res Clin Pract 1996. 34:7-11.
  112. Kajio H, Kobayashi T, Nakanishi K, Okubo M, Tsukada T, Nakayama T, Yamada N, Murase T, Yazaki Y, Kosaka K. Relationship between insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus: Beta-cell function, islet cell antibody, and haptoglobin in parents of IDDM patients. Metabolism 1995. 44:869-875.
  113. Kano Y, Kanatsuna T, Nakamura N, Kitagawa Y, Mori H, Kajiyama S, Nakano K, Kondo M. Defect of the first-phase insulin secretion to glucose stimulation in the perfused pancreas of the nonobese diabetic (NOD) mouse. Diabetes 1986. 35:486-490.
  114. Karounos DG, Bryson JS, Cohen DA. Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice. J Clin Invest 1997. 100:1344-1348.
  115. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GS, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993. 366:69-72.
  116. Lam-Tse WK, Lernmark A, Drexhage HA. Animal models of endocrine/organ-specific autoimmune diseases: Do they really help us to understand human autoimmunity? Springer Semin Immunopathol 2002. 24:297-321.
  117. Lefkowith J, Schreiner G, Cormier J, Handler ES, Driscoll HK, Greiner D, Mordes JP, Rossini AA. Prevention of diabetes in the BB rat by essential fatty acid deficiency: Relationship between physiological and biochemical changes. J Exp Med 1990. 171:729-743.
  118. Leiter EH. The genetics of diabetes susceptibility in mice. FASEB J 1989. 3:2231-2241.
  119. Leslie RD, Taylor R, Pozzilli P. The role of insulin resistance in the natural history of type 1 diabetes. Diabet Med 1997. 14:327-331.
  120. Lety MA, Coulaud J, Bens M, Dardenne M, Homo-Delarche F. Enhanced metabolism of arachidonic acid by macrophages from nonobese diabetic (NOD) mice. Clin Immunol Immunopathol 1992. 64:188-196.
  121. Like AA, Butler L, Williams RM, Appel MC, Weringer EJ, Rossini AA. Spontaneous autoimmune diabetes mellitus in the BB rat. Diabetes 1982. 31:7-13.
  122. Lindgren FA, Hartling SG, Dahlquist GG, Binder C, Efendic S, Persson BE. Glucose-induced insulin response is reduced and proinsulin response increased in healthy siblings of type 1 diabetic patients. Diabet Med 1991. 8:638-643.
  123. Lonnqvist F, Schalling M. Role of leptin and its receptor in human obesity. Curr Opin Endocrinol Diabetes 1997. 4:164-171.
  124. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998. 394:897-901.
  125. Lucas A, Boyes S, Bloom SR, Aynsley-Green A. Metabolic and endocrine responses to a milk feed in six-day-old term infants: Differences between breast and cow's milk formula feeding. Acta Paediatr Scand 1981. 70:195-200.
  126. MacDonald MJ, Liston L, Carlson I. Seasonality in glycosylated hemoglobin in normal subjects. Does seasonal incidence in insulin-dependent diabetes suggest specific etiology? Diabetes 1987. 36:265-268.
  127. Makino S, Kunimoto K, Muraoka Y, Katagiri K. Effect of castration on the appearance of diabetes in NOD mouse. Jikken Dobutsu 1981. 30:137-140.
  128. Martins TC, Aguas AP. Changes in B and T lymphocytes associated with mycobacteria-induced protection of NOD mice from diabetes. J Autoimmun 1996. 9:501-507.
  129. Martins TC, Aguas AP. Involvement of c-myc in the resistance of non-obese diabetic mice to glucocorticoid-induced apoptosis. Immunology 1998. 95:377-382.
  130. Martins TC, Aguas AP. NOD mice are resistant to depletion of thymic cells caused by acute stress or infection. Autoimmunity 1999. 29:273-280.
  131. Matarese G, Sanna V, Lechler RI, Sarvetnick N, Fontana S, Zappacosta S, La Cava A. Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 2002. 51:1356-1361.
  132. Mathis D, Vence L, Benoist C. Beta-cell death during progression to diabetes. Nature 2001. 414:792-798.
  133. Mondino A, Khoruts A, Jenkins MK. The anatomy of T-cell activation and tolerance. Proc Natl Acad Sci U S A 1996. 93:2245-2252.
  134. Moriyama H, Abiru N, Paronen J, Sikora K, Liu E, Miao D, Devendra D, Beilke J, Gianani R, Gill RG, Eisenbarth GS. Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc Natl Acad Sci U S A 2003. 100:10376-10381.
  135. Moriyama H, Eisenbarth GS. Genetics and environmental factors in endocrine/organ-specific autoimmunity: Have there been any major advances? Springer Semin Immunopathol 2002. 24:231-242.
  136. Nakajima H, Tochino Y, Fujino-Kurihara H, Yamada K, Gomi M, Tajima K, Kanaya T, Miyazaki A, Miyagawa J, Hanafusa T, et al. Decreased incidence of diabetes mellitus by monosodium glutamate in the non-obese diabetic (NOD) mouse. Res Commun Chem Pathol Pharmacol 1985. 50:251-257.
  137. Nakhooda AF, Like AA, Chappel CI, Wei CN, Marliss EB. The spontaneously diabetic Wistar rat (the "BB" rat): Studies prior to and during development of the overt syndrome. Diabetologia 1978. 14:199-207.
  138. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, Tsai MJ. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev 1997. 11:2323-2334.
  139. Notkins AL, Lernmark A. Autoimmune type 1 diabetes: Resolved and unresolved issues. J Clin Invest 2001. 108:1247-1252.
  140. Nyman T, Pekonen F. The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes. Acta Endocrinol (Copenh) 1993. 128:168-172.
  141. O'Brien BA, Huang Y, Geng X, Dutz JP, Finegood DT. Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 2002. 51:2481-2488.
  142. Ohneda A, Kobayashi T, Nihei J, Tochino Y, Kanaya H, Makino S. Insulin and glucagon in spontaneously diabetic non-obese mice. Diabetologia 1984. 27:460-463.
  143. Ong KK, Phillips DI, Fall C, Poulton J, Bennett ST, Golding J, Todd JA, Dunger DB. The insulin gene VNTR, type 2 diabetes and birth weight. Nat Genet 1999. 21:262-263.
  144. Orban T, Landaker E, Ruan Z, Cordeman TP, Weitgasser R, Bonner-Weir S, Jackson RA, Patti ME. High-fructose diet preserves beta-cell mass and prevents diabetes in nonobese diabetic mice: A potential role for increased insulin receptor substrate-2 expression. Metabolism 2001. 50:1369-1376.
  145. O'Reilly LA, Gu D, Sarvetnick N, Edlund H, Phillips JM, Fulford T, Cooke A. Alpha-cell neogenesis in an animal model of IDDM. Diabetes 1997. 46:599-606.
  146. Otonkoski T, Roivainen M, Vaarala O, Dinesen B, Leipala JA, Hovi T, Knip M. Neonatal type I diabetes associated with maternal echovirus 6 infection: A case report. Diabetologia 2000. 43:1235-1238.
  147. Owerbach D, Naya FJ, Tsai MJ, Allander SV, Powell DR, Gabbay KH. Analysis of candidate genes for susceptibility to type I diabetes: A case-control and family-association study of genes on chromosome 2q31-35. Diabetes 1997. 46:1069-1074.
  148. Paxson JA, Weber JG, Kulczycki A Jr. Cow's milk-free diet does not prevent diabetes in NOD mice. Diabetes 1997. 46:1711-1717.
  149. Pelegri C, Rosmalen JG, Durant S, Throsby M, Alves V, Coulaud J, Esling A, Pleau JM, Drexhage HA, Homo-Delarche F. Islet endocrine-cell behavior from birth onward in mice with the nonobese diabetic genetic background. Mol Med 2001. 7:311-319.
  150. Perretti M, Becherucci C, Scapigliati G, Parente L. The effect of adrenalectomy on interleukin-1 release in vitro and in vivo. Br J Pharmacol 1989. 98:1137-1142.
  151. Philippe J. Structure and pancreatic expression of the insulin and glucagon genes. Endocr Rev 1991. 12:252-271.
  152. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997. 40:1286-1292.
  153. Pleau JM, Esling A, Geutkens S, Dardenne M, Homo-Delarche F. Pancreatic hormone and glutamic acid decarboxylase expression in the mouse thymus: A real-time PCR study. Biochem Biophys Res Commun 2001. 283:843-848.
  154. Podar T, Onkamo P, Forsen T, Karvonen M, Tuomilehto-Wolf E, Tuomilehto J. Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes: DiMe Study Group. Diabetes Care 1999. 22:2092-2094.
  155. Polychronakos C, Kukuvitis A, Giannoukakis N, Colle E. Parental imprinting effect at the INS-IGF2 diabetes susceptibility locus. Diabetologia 1995. 38:715-719.
  156. Porte D, Woods SC. Neural regulation of islet hormones and its role in energy balance and stress hyperglycemia. In: Ellenberg M, Rifkins H, eds. Neural Regulation of Islet Hormones and Its Role in Energy Balance and Stress Hyperglycemia. New Hyde Park: Medical Examination Publication Co 1983. p 175-197.
  157. Pozzilli P. The DPT-1 trial: A negative result with lessons for future type 1 diabetes prevention. Diabetes Metab Res Rev 2002. 18:257-259.
  158. Pozzilli P, Signore A, Williams AJ, Beales PE. NOD mouse colonies around the world - Recent facts and figures. Immunol Today 1993. 14:193-196.
  159. Pugliese A, Miceli D. The insulin gene in diabetes. Diabetes Metab Res Rev 2002. 18:13-25.
  160. Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997. 15:293-297.
  161. Pundziute-Lycka A, Persson LA, Cedermak G, Jansson A, Nilsson U, Westin V, Dahlquist G. Diet, growth, and the risk of type 1 diabetes in childhood. Diabetologia 2003. 46(Suppl 2):A54.
  162. Rajagopalan G, Kudva YC, Flavell RA, David CS. Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules. Diabetes 2003. 52:342-347.
  163. Reddy S, Bibby NJ, Wu D, Swinney C, Barrow G, Elliott RB. A combined casein-free-nicotinamide diet prevents diabetes in the NOD mouse with minimum insulitis. Diabetes Res Clin Pract 1995. 29:83-92.
  164. Rhodes CJ, Alarcon C. What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes 1994. 43:511-517.
  165. Rich SS, Panter SS, Goetz FC, Hedlund B, Barbosa J. Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: Contributions of HLA and haptoglobin. Diabetologia 1991. 34:350-355.
  166. Roder ME, Knip M, Hartling SG, Karjalainen J, Akerblom HK, Binder C. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses: The Childhood Diabetes in Finland Study Group. J Clin Endocrinol Metab 1994. 79:1570-1575.
  167. Rodriguez-Villar C, Conget I, Casamitjana R, Vidal J, Manzanares JM, Gomis R. High proinsulin levels in late PRE-IDDM stage. Diabetes Res Clin Pract 1997. 37:145-148.
  168. Rosmalen JG, Leenen PJ, Pelegri C, Drexhage HA, Homo-Delarche F. Islet abnormalities in the pathogenesis of autoimmune diabetes. Trends Endocrinol Metab 2002. 13:209-214.
  169. Rosmalen JG, Pigmans MJ, Kersseboom R, Drexhage HA, Leenen PJ, Homo-Delarche F. Sex steroids influence pancreatic islet hypertrophy and subsequent autoimmune infiltration in nonobese diabetic (NOD) and NODscid mice. Lab Invest 2001. 81:231-239.
  170. Rosmalen JG, van Ewijk W, Leenen PJ. T-cell education in autoimmune diabetes: Teachers and students. Trends Immunol 2002. 23:40-46.
  171. Rossini AA, Handler ES, Mordes JP, Greiner DL. Human autoimmune diabetes mellitus: Lessons from BB rats and NOD mice - Caveat emptor. Clin Immunol Immunopathol 1995. 74:2-9.
  172. Sacks DB, McDonald JM. The pathogenesis of type II diabetes mellitus. A polygenic disease. Am J Clin Pathol 1996. 105:149-156.
  173. Saikumar P, Dong Z, Mikhailov V, Denton M, Weinberg JM, Venkatachalam MA. Apoptosis: Definition, mechanisms, and relevance to disease. Am J Med 1999. 107:489-506.
  174. Sakly M, Koch B. Ontogenesis of glucocorticoid receptors in anterior pituitary gland: Transient dissociation among cytroplasmic receptor density, nuclear uptake, and regulation of corticotropic activity. Endocrinology 1981. 108:591-596.
  175. Sammalkorpi K. Glucose intolerance in acute infections. J Intern Med 1989. 225:15-19.
  176. Saravia FE, Homo-Delarche F. Is innervation an early target in autoimmune diabetes? Trends Immunol 2003. 24:574-579.
  177. Saravia-Fernandez F, Durant S, el Hasnaoui A, Dardenne M, Homo-Delarche F. Environmental and experimental procedures leading to variations in the incidence of diabetes in the nonobese diabetic (NOD) mouse. Autoimmunity 1996. 24:113-121.
  178. Saravia-Fernandez F, Faveeuw C, Blasquez-Bulant C, Tappaz M, Throsby M, Pelletier G, Vaudry H, Dardenne M, Homo-Delarche F. Localization of gamma-aminobutyric acid and glutamic acid decarboxylase in the pancreas of the nonobese diabetic mouse. Endocrinology 1996. 137:3497-3506.
  179. Savino W, Dardenne M. Immune-neuroendocrine interactions. Immunol Today 1995. 16:318-322.
  180. Scott FW, Marliss EB. Conference summary: Diet as an environmental factor in development of insulin-dependent diabetes mellitus. Can J Physiol Pharmacol 1991. 69:311-319.
  181. Scott FW, Sarwar G, Cloutier HE. Diabetogenicity of various protein sources in the diet of the diabetes-prone BB rat. Adv Exp Med Biol 1988. 246:277-285.
  182. Seckl JR. Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms. Mol Cell Endocrinol 2001. 185:61-71.
  183. Senecat O, Martignat L, Elmansour A, Charbonnel B, Sai P. Diabetes enhancement and increased islet antigen expression following neonatal injections of glucose and arginine in non-obese diabetic mice. Metabolism 1994. 43:1410-1418.
  184. She JX, Marron MP. Genetic susceptibility factors in type 1 diabetes: Linkage, disequilibrium and functional analyses. Curr Opin Immunol 1998. 10:682-689.
  185. Smith CL, Hammond GL. An amino acid substitution in biobreeding rat corticosteroid binding globulin results in reduced steroid binding affinity. J Biol Chem 1991. 266:18555-18559.
  186. Smith KM, Olson DC, Hirose R, Hanahan D. Pancreatic gene expression in rare cells of thymic medulla: Evidence for functional contribution to T cell tolerance. Int Immunol 1997. 9:1355-1365.
  187. Sorenson RL, Garry DG, Brelje TC. Structural and functional considerations of GABA in islets of Langerhans: Beta-cells and nerves. Diabetes 1991. 40:1365-1374.
  188. Spinas GA, Snorgaard O, Hartling SG, Oberholzer M, Berger W. Elevated proinsulin levels related to islet cell antibodies in first-degree relatives of IDDM patients. Diabetes Care 1992. 15:632-637.
  189. Spinedi E, Hadid R, Gaillard RC. Increased vasopressinergic activity as a possible compensatory mechanism for a normal hypothalamic-pituitary-adrenal axis response to stress in BALB/c nude mice. Neuroendocrinology 1997. 66:287-293.
  190. Stene LC, Magnus P, Lie RT, Sovik O, Joner G. Birth weight and childhood onset type 1 diabetes: Population based cohort study. Br Med J 2001. 322:889-892.
  191. Strandell E, Sandler S, Boitard C, Eizirik DL. Role of infiltrating T cells for impaired glucose metabolism in pancreatic islets isolated from non-obese diabetic mice. Diabetologia 1992. 35:924-931.
  192. Talal N, Ansar Ahmed S. Sex hormones and autoimmune diseases: A short review. Int J Immunother 1987. 3:65-70.
  193. Teruya M, Takei S, Forrest LE, Grunewald A, Chan EK, Charles MA. Pancreatic islet function in nondiabetic and diabetic BB rats. Diabetes 1993. 42:1310-1317.
  194. Thebault-Baumont K, Dubois-Laforgue D, Krief P, Briand JP, Halbout P, Vallon-Geoffroy K, Morin J, Laloux V, Lehuen A, Carel JC, Jami J, Muller S, Boitard C. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest 2003. 111:851-857.
  195. Thompson A, Arany EJ, Hill DJ, Yang K. Glucocorticoid receptor expression is altered in pancreatic beta cells of the non-obese diabetic mouse during postnatal development. Metabolism 2002. 51:765-768.
  196. Throsby M, Homo-Delarche F, Chevenne D, Goya R, Dardenne M, Pleau JM. Pancreatic hormone expression in the murine thymus: Localization in dendritic cells and macrophages. Endocrinology 1998. 139:2399-2406.
  197. Throsby M, Pleau J, Dardenne M, Homo-Delarche F. Thymic expression of the pancreatic endocrine hormones. Neuroimmunomodulation 1999. 6:108-114.
  198. Tilders FJ, DeRijk RH, Van Dam AM, Vincent VA, Schotanus K, Persoons JH. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: Routes and intermediate signals. Psychoneuroendocrinology 1994. 19:209-232.
  199. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993. 366:72-75.
  200. Todd JA. Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci U S A 1995. 92:8560-8565.
  201. Todd JA, Wicker LS. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 2001. 15:387-395.
  202. Vaarala O, Hyoty H, Akerblom HK. Environmental factors in the aetiology of childhood diabetes. Diabetes Nutr Metab 1999. 12:75-85.
  203. Vafiadis P, Bennett ST, Colle E, Grabs R, Goodyer CG, Polychronakos C. Imprinted and genotype-specific expression of genes at the IDDM2 locus in pancreas and leucocytes. J Autoimmun 1996. 9:397-403.
  204. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, Polychronakos C. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997. 15:289-292.
  205. Vafiadis P, Grabs R, Goodyer CG, Colle E, Polychronakos C. A functional analysis of the role of IGF2 in IDDM2-encoded susceptibility to type 1 diabetes. Diabetes 1998. 47:831-836.
  206. Vallette G, Delorme J, Benassayag C, Savu L, Nunez EA, Meijs-Roelofs HM, Kramer P. Developmental patterns of levels of corticosterone and of corticosterone binding in the serum of female rats: Effects of ovariectomy and adrenalectomy. Acta Endocrinol (Copenh) 1982. 101:442-451.
  207. Verheul HA, Verveld M, Hoefakker S, Schuurs AH. Effects of ethinylestradiol on the course of spontaneous autoimmune disease in NZB/W and NOD mice. Immunopharmacol Immunotoxicol 1995. 17:163-180.
  208. Vezys V, Lefrancois L. Cutting edge: Inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J Immunol 2002. 169:6677-6680.
  209. Wasmuth HE, Hess G, Viergutz C, Henrichs HR, Martin S, Kolb H. Non-specific viral infections as possible synchronising events of the manifestation of type 1 diabetes. Diabetes Metab Res Rev 2000. 16:177-178.
  210. Wegmann DR. The immune response to islets in experimental diabetes and insulin-dependent diabetes mellitus. Curr Opin Immunol 1996. 8:860-864.
  211. Weisz J, Ward IL. Plasma testosterone and progesterone titers of pregnant rats, their male and female fetuses, and neonatal offspring. Endocrinology 1980. 106:306-316.
  212. Williams AJ, Beales PE, Krug J, Procaccini E, Signore A, Xu S, Gale EA, Pozzilli P. Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-obese-diabetic mouse. Diabetologia 1993. 36:487-492.
  213. Williams AJ, Krug J, Lampeter EF, Mansfield K, Beales PE, Signore A, Gale EA, Pozzilli P. Raised temperature reduces the incidence of diabetes in the NOD mouse. Diabetologia 1990. 33:635-637.
  214. Winer S, Tsui H, Lau A, Song A, Li X, Cheung RK, Sampson A, Afifiyan F, Elford A, Jackowski G, Becker DJ, Santamaria P, Ohashi P, Dosch HM. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. Nat Med 2003. 9:198-205.
  215. Wogensen LD, Kolb-Bachofen V, Christensen P, Dinarello CA, Mandrup-Poulsen T, Martin S, Nerup J. Functional and morphological effects of interleukin-1 beta on the perfused rat pancreas. Diabetologia 1990. 33:15-23.
  216. Wright JR Jr, Haliburton B, Russell H, Henry M, Fraser R, Cook HW. The anti-diabetogenic effect of essential fatty acid deficiency in multiple low-dose streptozotocin-treated mice persists if essential fatty acid repletion occurs outside of a brief window of susceptibility. Diabetologia 1991. 34:709-714.
  217. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 2001. 50:1110-1118.
  218. Yki-Jarvinen H, Sammalkorpi K, Koivisto VA, Nikkila EA. Severity, duration, and mechanisms of insulin resistance during acute infections. J Clin Endocrinol Metab 1989. 69:317-323.
  219. Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K, Eisenbarth GS. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: Evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A 2000. 97:1701-1706.
  220. Zeidler A, Edwards P, Goldman J, Kort S, Meehan WP, Levin SR. Hyperglycemic athymic nude mice: Factors affecting in vitro insulin secretion. Am J Physiol 1992. 263:E1131-1133.
  221. Zeidler A, Shargill NS, Chan TM. Peripheral insulin insensitivity in the hyperglycemic athymic nude mouse: Similarity to noninsulin-dependent diabetes mellitus. Proc Soc Exp Biol Med 1991. 196:457-460.
  222. Zella JB, DeLuca HF. Vitamin D and autoimmune diabetes. J Cell Biochem 2003. 88:216-222.
  223. Zumsteg U, Reimers JI, Pociot F, Morch L, Helqvist S, Brendel M, Alejandro R, Mandrup-Poulsen T, Dinarello CA, Nerup J. Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells: Studies in rodent and human islets and in normal rats. Diabetologia 1993. 36:759-766.

Articles citing this article:


 
Respond on this Journal Article!
Hint: Your Response should directly apply to Neuroendocrine immuno-ontogeny of the pathogenesis of autoimmune disease in the nonobese diabetic (NOD) mouse.. Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate subject area. The actual subject area is Macrophage Infiltration.

 

    
   
About DOD | Advertising Information | Support The Project | DOD alert | Become Editor
Copyright by SBDR © 2002-2007. All rights reserved | Last Change: 2006/12/21
Recommend this Page! | Print page  | Sitemap | Contact | Privacy